| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/06/2008 | EP1952821A1 Therapeutic agent for dentine-dental pulp complex regeneration |
| 08/06/2008 | EP1952820A2 Protein-free G-CSF formulations |
| 08/06/2008 | EP1952819A2 Method for preventing gastritis using amylin or amylin agonists |
| 08/06/2008 | EP1952818A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 08/06/2008 | EP1952802A2 Buccal, polar and non-polar spray or capsule |
| 08/06/2008 | EP1952700A1 Method of improving absorption of vitamin E by a pet animal |
| 08/06/2008 | EP1951908A2 Fgf2-related methods for diagnosing and treating depression |
| 08/06/2008 | EP1951890A2 Methods and compositions comprising non-natural amino acids |
| 08/06/2008 | EP1951889A2 Vancomycin formulations having reduced amount of histamine |
| 08/06/2008 | EP1951750A2 Modulation of angiogenesis by a-beta peptide fragments |
| 08/06/2008 | EP1951745A2 Casein-derived antimicrobial peptides and lactobacillus strains that produce them |
| 08/06/2008 | EP1951743A1 Hepatitis c virus inhibitors |
| 08/06/2008 | EP1951740A2 High affinity siglec ligands |
| 08/06/2008 | EP1951319A2 Chimeric immunoreceptor useful in treating human cancers |
| 08/06/2008 | EP1951311A1 Lipopeptide compositions |
| 08/06/2008 | EP1951293A1 Agent for use in the case of disorders of blood sugar metabolism, including diabetes |
| 08/06/2008 | EP1951292A2 Lysozyme fortified milk and milk products |
| 08/06/2008 | EP1951291A1 Methods of regulating renalase (monoamine oxidase c) |
| 08/06/2008 | EP1951290A2 Agent for use in the case of fructose intolerance |
| 08/06/2008 | EP1951289A2 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| 08/06/2008 | EP1951288A2 Method of enhancing the immune response to a vaccine |
| 08/06/2008 | EP1951287A2 Medicament for treating problems relating to fertility and pregnancy, and auto-immune diseases, and for inducing an immunological tolerance in transplant patients, and method for producing said medicament |
| 08/06/2008 | EP1951286A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 08/06/2008 | EP1951285A2 Interferon in influenza |
| 08/06/2008 | EP1951284A2 Improved variants of pigment epithelium derived factor and uses thereof |
| 08/06/2008 | EP1951283A1 Pharmaceutical composition for treating or preventing ovarian cancer |
| 08/06/2008 | EP1951282A1 Treatment of hypersensitivity |
| 08/06/2008 | EP1951281A2 Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| 08/06/2008 | EP1951279A2 Compstatin and analogs thereof for eye disorders |
| 08/06/2008 | EP1951278A2 Methods and compositions for derepression of iap-inhibited caspase |
| 08/06/2008 | EP1951277A2 Natriuretic peptide modified transferrin fusion proteins |
| 08/06/2008 | EP1951276A1 Oligopeptides and their use |
| 08/06/2008 | EP1951259A1 Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor |
| 08/06/2008 | EP1951218A1 Medicament for use in connection with cartilage impairment |
| 08/06/2008 | EP1951207A2 Pharmaceutical composition |
| 08/06/2008 | EP1951194A2 Antimicrobial decapeptide oral hygiene treatment |
| 08/06/2008 | EP1951063A1 Ultra high pressure modified proteins and uses thereof |
| 08/06/2008 | EP1748785B1 Peptides for the modulation of cartilage homeostasis |
| 08/06/2008 | EP1585546B1 Kim-1 antagonists and use to modulate immune system |
| 08/06/2008 | EP1557465B1 Cap-binding protein |
| 08/06/2008 | EP1508047B1 Method for identifying immunoreactive peptides |
| 08/06/2008 | EP1498487B1 35 kd protein |
| 08/06/2008 | EP1495051B1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/06/2008 | EP1478777B1 Genetic marker for diffentiating mycobacteria |
| 08/06/2008 | EP1474144B1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 08/06/2008 | EP1467710B1 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support |
| 08/06/2008 | EP1366059B1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/06/2008 | EP1350521B1 Immunotherapeutic combinations for the treatment of tumors |
| 08/06/2008 | EP1326879B1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1205185B1 Uterine contraction inhibitors |
| 08/06/2008 | EP1192277B1 Diagnosis of restenosis |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1042467B1 Non-identical genes and their application in improved molecular adjuvants |
| 08/06/2008 | EP1023447B1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 08/06/2008 | EP1005274B1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
| 08/06/2008 | EP0941241B1 Bordetella strain expressing the fha hybrid, |
| 08/06/2008 | EP0938548B1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 08/06/2008 | EP0832109B1 Fibroblast growth factor homologous factor-2 and methods of use |
| 08/06/2008 | EP0744409B1 Platelet growth accelerator |
| 08/06/2008 | EP0722336B1 Recombinant coffee bean alpha-galactosidase |
| 08/06/2008 | EP0666911B9 Multidrug resistance gene |
| 08/06/2008 | CN101238145A Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins |
| 08/06/2008 | CN101237892A Method of conjugating aminothiol containing molecules to vehicles |
| 08/06/2008 | CN101237880A Methods of treating diseases with a VEGF antagonist |
| 08/06/2008 | CN101237879A 抗凝剂及其用途 Anticoagulants and their use |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237877A Methods of improving cardiac function and attenuating and/orpreventing cardiac remodeling with HSP20 |
| 08/06/2008 | CN101237870A Concomitant pharmaceutical agents and use thereof |
| 08/06/2008 | CN101237850A Pharmaceutical composition containing indometacin and/or acemetacin |
| 08/06/2008 | CN101237785A High pressure processing of metal ion lactoferrin |
| 08/06/2008 | CN101235367A Method for preparing ganoderma sinensis streptokinase and application thereof |
| 08/06/2008 | CN101235083A HIV-I resisting polypeptide, coded sequence and use thereof |
| 08/06/2008 | CN101235079A Short peptide for inhibiting growing of liver cancer cell and application thereof |
| 08/06/2008 | CN101234200A Composition for improving and treating human body digestive system a plurality of malaise symptoms |
| 08/06/2008 | CN101234195A Compound gargle for preventing and controlling stomatitis and confecting method thereof |
| 08/06/2008 | CN101234194A Biological information medical insurance medicine for recovering sex function carbohydrate metabolism function and preparation technique |
| 08/06/2008 | CN101234193A Stable water solution containing recombination human serum albumin fusion interferon |
| 08/06/2008 | CN101234192A Activated plasma thromboplastin component VII for treating massive haemorrhage caused by thrombolysis therapy |
| 08/06/2008 | CN101234191A Use of human recombination hepatic stimulator substance for reinforcing anti-apoptosis of liver cancer cell and application thereof |
| 08/06/2008 | CN101234190A Use of apolipoprotein A-I in preparing medicaments for inhibiting G+ bacteria infection induced sepsis and tissue inflammation damnification |
| 08/06/2008 | CN101234096A Pidotimod capsule preparation and preparation thereof |
| 08/06/2008 | CN101234089A Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof |
| 08/06/2008 | CN100408683C HLA-A24-restricted cancer antigen peptide |
| 08/06/2008 | CN100408597C Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use |
| 08/06/2008 | CN100408595C SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 08/06/2008 | CN100408101C Gene therapy for critical limb ischemia with wild type or mutant eNOS |
| 08/06/2008 | CN100408100C Ophthalmic compositions containing galactomannan polymers and borate |
| 08/06/2008 | CN100408094C Application of protease inhibitor for protecting hepatocyte function |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408091C Recombination human granul ocyte-macrophage colong stimulating factor ges and its preparation method |
| 08/06/2008 | CN100408090C Recombinant human interferon-beta-1b polypeptides |
| 08/06/2008 | CN100408089C Animal medicine capable of resisting multiple irritated stress of chicken |
| 08/06/2008 | CN100408088C Medicine for treating oral ulcer |
| 08/06/2008 | CN100408087C Medicine for treating bronchial asthma |
| 08/05/2008 | US7408053 Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby |
| 08/05/2008 | US7408042 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |